CClinicalTrials.gg
Status unknownNCT04116892CAOLMHSUpdated Oct 27, 2020

Comparative Analysis of Large Macular Hole Surgeries

An interventional study of the Cover group and the Fill group in Macular Holes, sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University. Status unknown at 1 site in China. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2020-10-27.

Sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Oct 2020), so the status shown — last known as Recruiting — may be out of date.

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled May 2019, registered Sep 2019).
Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Non-randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

This study compares the anatomical and visual outcomes in a large series of patients affected by idiopathic macular holes larger than 400 µm treated using pars plana vitrectomy and gas tamponade combined with internal limiting membrane (ILM) peeling or the inverted internal limiting membrane flap technique. A part of the participants will receive internal limiting membrane peeling,whil the other will receive the inverted internal limiting membrane flap technique.

Read the detailed description

Vitrectomy is the standard treatment for idiopathic macular holes (IMHs) and is combined with removal of the internal limiting membrane (ILM) to improve anatomical outcomes.However, surgical closure is not achieved after a single operation in all cases, and patients with long-standing MHs or highly myopic eyes are challenging to treat.Various surgical strategies have been introduced to improve postoperative outcomes for these cases. Michalewska et al. have reported an inverted ILM flap technique for large MHs. The ILM around the MH was left to cover or fill the hole and showed a better anatomical closure rate and visual outcome than ILM peeling for large MHs. Nevertheless, the functional and anatomic outcomes of the ILM flap technique have not been investigated as extensively as the ILM peeling technique and have yet to be confirmed by research comparing the ILM flap technique with the conventional procedure.

02

Conditions studied

  • Macular Holes

Browse trials for

Keywords

  • Inverted Internal Limiting Membrane Flap Technique
  • Large Macular Hole
  • Macular hole surgery
03

In context

Retinal Perforations

156 studies on the registry are indexed under Retinal Perforations; 21 are open to participants now.

This study's planned enrollment of 100 is above the median of 44 across 104 interventional studies indexed under Retinal Perforations.

Browse Retinal Perforations studies →

Lead sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University is the lead sponsor of 1,058 studies on the registry; 511 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • idiopathic MHs, a minimum hole diameter of ≥ 400 μm, and follow-up for at least 3 months after vitrectomy.

Exclusion criteria

Exclusion Criteria:

  • High myopia (≥6 diopters,AL≥26.5mm), increased intraocular pressure (IOP, >21 mm Hg) or glaucoma, severe cataract, severe systemic conditions that prevent surgery, and history of ocular trauma, intraocular inflammation, retinal vascular disease, or previous ocular surgery.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Sequential assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
100 participants (estimated)

Study arms

  • Active comparator
    the peeling group

    the internal limiting membrane was discarded

    Procedure: the peeling group

  • Experimental
    the Cover group

    the internal limiting membrane was peeled centripetally all the way up to the MH rim and the hinged ILM flap folded upside-down on top of the MH in order to bridge the entire retinal defect with a single layer.

    Procedure: the Cover group

  • Experimental
    the Fill group

    the internal limiting membrane was folded in multiple layers and deliberately "stuffed" or "packed" within the MH defect using a forceps.

    Procedure: the Fill group

Interventions

  • Procedurethe Cover group

    The internal limiting membrane around the MH was left to cover the hole

  • Procedurethe Fill group

    The internal limiting membrane around the MH was left to fill the hole

  • Procedurethe peeling group

    the internal limiting membrane was discarded

06

What researchers measure

Primary outcomes

  1. MH status

    MH status (open, flat open or closed)

    Time frame: at 3 months after surgery

  2. IS/OS line interruption width

    IS/OS line interruption width were gauged with spectral-domain optical coherence tomography

    Time frame: at 3 months after surgery

  3. Change from Baseline IS/OS line interruption width at 3 months

    IS/OS line interruption width were gauged with spectral-domain optical coherence tomography

    Time frame: at 3 months after surgery

  4. Baseline best-corrected visual acuity

    best-corrected visual acuity were gauged with EDTRS charts,recorded in decimals and was converted to logarithm of the minimum angle of resolution units for statistical analysis

    Time frame: at 3 months after surgery

  5. Change from Baseline best-corrected visual acuity at 3 months

    best-corrected visual acuity were gauged with EDTRS charts,recorded in decimals and was converted to logarithm of the minimum angle of resolution units for statistical analysis

    Time frame: at 3 months after surgery

  6. visual function

    visual function were gauged with national eye institute visual function questionnaire-25((NEI VFQ-25)

    Time frame: at 3 months after surgery

  7. Change from Baseline visual function at 3 months

    visual function were gauged with national eye institute visual function questionnaire-25((NEI VFQ-25)

    Time frame: at 3 months after surgery

07

Study locations

1 of 1 sites recruiting
  • Department of Ophthalmology, The Second Affiliated Hospital, Zhejiang University School of Medicine
    Hangzhou, Zhejiang, China
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 27, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04116892
Lead sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Responsible party
Sponsor
First posted
Oct 7, 2019
Start date
May 1, 2019
Primary completion
Jun 30, 2021 (estimated)
Completion
Sep 30, 2021 (estimated)
Last update
Oct 27, 2020

Study contacts

Zhiyong Zhang, docter
Contact
zhangziyongnet@163.com
13968059392
Tao Jiang
principal investigator · Second Affiliated Hospital, School of Medicine, Zhejiang University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion